The global syndrome therapeutics market size was valued at US$ 147.4 Mn in 2024 and is projected to reach US$ 407.3 Mn by ...

The initial grey market trends suggest a positive listing gain of around 12-20% for the mainboard offers of Excelsoft Technologies and Sudeep Pharma.

For millions struggling with thinning hair, KX-826 is fast becoming more than just a solution - it’s a quiet revolution in ...

Shares of Sudeep Pharma are trading at a 19% premium in the unlisted market, with the current grey market premium (GMP) of ...

Introduction Medication use during pregnancy is common, and socioeconomic disparities in access may contribute to maternal ...

Currently, drug licences do not explicitly ban advertising. The draft proposes making prohibition of advertisements for ...

Shares tumble to a six-month low after mayhem on Wall Street; Treasuer Jim Chalmers rejects Cosette’s takeover of Mayne Pharma; Lovisa same store sales slow; Webjet bidding war heats up. Follow live.

OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

The firm will initially seek approval in patients who've had prior ALK inhibitors but has ambitions to eventually make neladalkib a first-line option.

The companies will submit data showing zipalertinib resulted in a 35.2 percent response rate in patients with exon 20 mutations.

HERZLIYA, Israel and CALGARY, AB, Nov. 20, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...